Covid-19, Acute Myocardial Infarctions and Strokes in France

Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04542083

Acronym

COVUSI

Enrollment

911

Registered

2020-09-09

Start date

2021-09-20

Completion date

2023-07-25

Last updated

2023-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cardiovascular Condition, Acute Myocardial Infarction, Acute Neurovascular Condition, COVID-19, Stroke

Brief summary

The COVID-19 pandemic has had dramatic effects on health systems and on non-COVID health care. Using French inpatient claims data and retrospectively collected clinical data, the investigators will assess the changes in hospital admissions for acute cardiovascular and neurovascular conditions in France during and after the national lockdown.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Adults admitted in 2018, 2019 or 2020 in a French hospital for acute coronary syndrom or stroke

Exclusion criteria

\- None

Design outcomes

Primary

Measure	Time frame	Description
Daily number of admissions for acute cardio- and neurivascular conditions in France.	1 day	Daily number of admissions for acute cardio- and neurivascular conditions in France.

Secondary

Measure	Time frame	Description
Specific mortality rate.	1 day	Specific mortality rate.

Countries

France

Outcome results